VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO 2022 | Long-term survivorship challenges in advanced urothelial cancer

Jonathan E. Rosenberg, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, provides an overview of survivorship challenges faced by patients with bladder cancer, which vary with extent and stage of disease. In metastatic patients, peripheral neuropathy is a long-term toxicity associated with the use of enfortumab vedotin, an antibody-drug conjugate. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter